| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases
|
Bess, Adam
|
|
|
27 |
4 |
p. 1099-1107
|
artikel
|
| 2 |
Bigels as drug delivery systems: From their components to their applications
|
Martín-Illana, Araceli
|
|
|
27 |
4 |
p. 1008-1026
|
artikel
|
| 3 |
Blockchain in pharmaceutical life cycle management
|
Omidian, Hossein
|
|
|
27 |
4 |
p. 935-938
|
artikel
|
| 4 |
Challenges and hopes for Alzheimer’s disease
|
Tatulian, Suren A.
|
|
|
27 |
4 |
p. 1027-1043
|
artikel
|
| 5 |
Chemokines and chemokine receptors in inflammatory bowel disease: Recent findings and future perspectives
|
Camba-Gómez, Miguel
|
|
|
27 |
4 |
p. 1167-1175
|
artikel
|
| 6 |
Communicating regulatory high-throughput sequencing data using BioCompute Objects
|
King IV, Charles Hadley S.
|
|
|
27 |
4 |
p. 1108-1114
|
artikel
|
| 7 |
Contents page
|
|
|
|
27 |
4 |
p. i-ii
|
artikel
|
| 8 |
Drug discovery efforts toward inhibitors of canonical Wnt/β-catenin signaling pathway in the treatment of cancer: A composition-of-matter review (2010–2020)
|
Morris, Andrew
|
|
|
27 |
4 |
p. 1115-1127
|
artikel
|
| 9 |
Drug discovery for epigenetics targets
|
Holdgate, Geoffrey A.
|
|
|
27 |
4 |
p. 1088-1098
|
artikel
|
| 10 |
Engineering nanoparticle therapeutics for impaired wound healing in diabetes
|
Shamiya, Yasmeen
|
|
|
27 |
4 |
p. 1156-1166
|
artikel
|
| 11 |
Enhancing access to innovative cancer drugs: Cross-sector consensus on a way forward to benefit patients
|
Hoey, Richard
|
|
|
27 |
4 |
p. 946-950
|
artikel
|
| 12 |
Enhancing preclinical drug discovery with artificial intelligence
|
Vijayan, R.S.K.
|
|
|
27 |
4 |
p. 967-984
|
artikel
|
| 13 |
How much do the public sector and the private sector contribute to biopharmaceutical R&D?
|
Simoens, Steven
|
|
|
27 |
4 |
p. 939-945
|
artikel
|
| 14 |
ImmunoPET imaging of hematological malignancies: From preclinical promise to clinical reality
|
Dun, Yiting
|
|
|
27 |
4 |
p. 1196-1203
|
artikel
|
| 15 |
Modulating CRISPR/Cas9 genome-editing activity by small molecules
|
Chen, Siwei
|
|
|
27 |
4 |
p. 951-966
|
artikel
|
| 16 |
Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives
|
Lagoutte-Renosi, Jennifer
|
|
|
27 |
4 |
p. 985-1007
|
artikel
|
| 17 |
Multicompartment systems: A putative carrier for combined drug delivery and targeting
|
Gautam, Laxmikant
|
|
|
27 |
4 |
p. 1184-1195
|
artikel
|
| 18 |
Organoid and microfluidics-based platforms for drug screening in COVID-19
|
Ramezankhani, Roya
|
|
|
27 |
4 |
p. 1062-1076
|
artikel
|
| 19 |
Stromal disruption facilitating invasion of a ‘nano-arsenal’ into the solid tumor
|
Fu, Yige
|
|
|
27 |
4 |
p. 1132-1141
|
artikel
|
| 20 |
Targeting protein interaction networks in mitochondrial dynamics for cancer therapy
|
Yin, Chieh-Fan
|
|
|
27 |
4 |
p. 1077-1087
|
artikel
|
| 21 |
The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma
|
Jain, Rupesh
|
|
|
27 |
4 |
p. 1176-1183
|
artikel
|
| 22 |
Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
|
Baghaei, Kaveh
|
|
|
27 |
4 |
p. 1044-1061
|
artikel
|
| 23 |
The rebirth of isolated organ contraction studies for drug discovery and repositioning
|
Borges, Ricardo
|
|
|
27 |
4 |
p. 1128-1131
|
artikel
|
| 24 |
Update on treatment strategies for vasculitis affecting the central nervous system
|
Hecker, Constantin
|
|
|
27 |
4 |
p. 1142-1155
|
artikel
|
Tijdschrift beschrijving